These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2566160)

  • 21. Salbutamol plus beclomethasone dipropionate versus theophylline for the prevention of methacholine-induced bronchospasm in patients with chronic bronchitis.
    Arossa W; Spinaci S; Testi R
    Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):565-8. PubMed ID: 4066080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dose-response comparison of broxaterol and salbutamol pressurized aerosols.
    Simone P; Borgia M; Torre L; Ventresca GP
    Eur J Clin Pharmacol; 1990; 39(6):565-8. PubMed ID: 1982761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bronchodilating activity of broxaterol transdermal patch and its protective effect on bronchial constriction induced by inhaled distilled water mist.
    Robuschi M; Gambaro G; Spagnotto S; Scuri M; Fai V; Lodola E; Pisati R; Bianco S
    Int J Clin Pharmacol Ther Toxicol; 1991 Oct; 29(10):407-11. PubMed ID: 1684178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparison of the bronchodilating effects of five beta-adrenergic stimulants administered by inhalation to patients with bronchial asthma].
    Kokubu H
    Arerugi; 1993 Jun; 42(6):699-705. PubMed ID: 8102230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pretreatment with albuterol versus montelukast for exercise-induced bronchospasm in children.
    Raissy HH; Harkins M; Kelly F; Kelly HW
    Pharmacotherapy; 2008 Mar; 28(3):287-94. PubMed ID: 18294107
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential effects of nifedipine and diltiazem on methacholine-induced bronchospasm in allergic asthma.
    Ferrari M; Olivieri M; De Gasperi M; Lechi A
    Ann Allergy; 1989 Sep; 63(3):196-200. PubMed ID: 2672909
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Double-blind comparison of tulobuterol and salbutamol in chronic obstructive pulmonary disease.
    Germouty J
    Clin Ther; 1986; 8(5):546-53. PubMed ID: 2876775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of acute bronchospasm in pediatric populations.
    Chipps BE
    Postgrad Med; 2005 Dec; 118(6 Suppl Acute):39-43; discussion 43. PubMed ID: 19667715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preliminary study on the effect of broxaterol on bronchial hyperresponsiveness in asthmatic children: influence of allergen exposure.
    Benedetti M; Spezia E; Comis A; Marcer G; Boner AL
    Respiration; 1993; 60(6):319-24. PubMed ID: 7904767
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pharmacokinetics of broxaterol in asthmatic children].
    Flores D'Arcais A; Crippa L; De Biase D; Romagnoni G
    Minerva Pediatr; 1992 Sep; 44(9):421-5. PubMed ID: 1361960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Broxaterol: a new beta2-adrenoceptor agonist for the treatment of reversible airways disease. Proceedings of the satellite symposium. Budapest, September 8, 1988.
    Respiration; 1989; 55 Suppl 2():1-44. PubMed ID: 2572034
    [No Abstract]   [Full Text] [Related]  

  • 32. The protective effect of transdermal broxaterol on exercise-induced bronchoconstriction.
    Robuschi M; Scuri M; Spagnotto S; Gambaro G; Lodola E; Pisati R; Bianco S
    Eur J Clin Pharmacol; 1995; 47(5):465-6. PubMed ID: 7720771
    [No Abstract]   [Full Text] [Related]  

  • 33. Evaluation of the protective effect of a new beta-agonist, KWD 2131, on allergen-induced bronchospasm.
    Hegardt B; Löwhagen O; Svedmyr N
    Allergy; 1980 Jul; 35(5):413-9. PubMed ID: 6108726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the protective action of Salbutamol Polfa--aerosol in relation to histamine induced bronchospasm in patients with bronchial asthma, in comparison with the effect of Ventolin-Pliva, Astmopent-Polfa and Berotec-Boehringer.
    Rozniecki J; Szmidt M; Grabski W; Gondorowicz K
    Mater Med Pol; 1977; 9(4):331-5. PubMed ID: 599965
    [No Abstract]   [Full Text] [Related]  

  • 35. Broxaterol: pharmacological profile of a unique structural feature.
    Della Bella D
    Respiration; 1989; 55 Suppl 2():10-4. PubMed ID: 2572035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Current evaluation of beta-adrenergic agents in the treatment of bronchial spasm].
    Cornia G; Mannino F; Pasqua F; Giammarruto R; Mariotta S
    Minerva Med; 1975 Nov; 66(77):4056-8. PubMed ID: 241949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New drug evaluation using exercise-induced bronchospasm.
    Sprenkle AC; VanArsdel PP; Biermann CW
    Pediatrics; 1975 Nov; 56(5 pt-2 suppl):937-9. PubMed ID: 1187285
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A trial of nebulized magnesium sulfate to reverse bronchospasm in asthmatic patients.
    Chande VT; Skoner DP
    Ann Emerg Med; 1992 Sep; 21(9):1111-5. PubMed ID: 1514723
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Usefulness of new beta 2 stimulant drugs on bronchospasm].
    Palomar Aranzubia FP; Alcoba Almecija MC
    Rev Clin Esp; 1977 Jun; 145(5):329-34. PubMed ID: 17886
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical experimentation with salbutamol in bronchial obstructive diseases of early infancy].
    Picchioni P; Minelli P
    Minerva Pediatr; 1977 Feb; 29(5):311-4. PubMed ID: 323678
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.